A
Aldo P. Maggioni
Researcher at European Society of Cardiology
Publications - 1044
Citations - 104828
Aldo P. Maggioni is an academic researcher from European Society of Cardiology. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 134, co-authored 940 publications receiving 90242 citations. Previous affiliations of Aldo P. Maggioni include University of Bologna & University of Belgrade.
Papers
More filters
Journal ArticleDOI
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
S. Adamopoulos,Stefan D. Anker,Volkmar Falk,Lars Køber,Aldo P. Maggioni,Alexander Parkhomenko,Burkert Pieske,Bogdan A. Popescu,Frans H. Rutten,Juerg Schwitter,Pedro T. Trindade,Adriaan A. Voors,Andreas M. Zeiher +12 more
TL;DR: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure have been developed in collaboration with the Heart Failure Association (HFA) of the ESC 2012 Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 as mentioned in this paper.
Journal ArticleDOI
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot,Udo Sechtem,Stephan Achenbach,Felicita Andreotti,Chris Arden,Andrzej Budaj,Raffaele Bugiardini,Filippo Crea,Thomas Cuisset,Carlo Di Mario,J. Rafael Ferreira,Bernard J. Gersh,Anselm K. Gitt,Jean-Sébastien Hulot,Nikolaus Marx,Lionel H. Opie,Matthias Pfisterer,Eva Prescott,Frank Ruschitzka,Manel Sabaté,Roxy Senior,David P. Taggart,Ernst E. van der Wall,Christiaan J. Vrints,José Luis Zamorano,Helmut Baumgartner,Jeroen J. Bax,Héctor Bueno,Veronica Dean,Christi Deaton,Çetin Erol,Robert Fagard,Roberto Ferrari,David Hasdai,Arno W. Hoes,Paulus Kirchhof,Juhani Knuuti,Philippe Kolh,Patrizio Lancellotti,Aleš Linhart,Petros Nihoyannopoulos,Massimo F Piepoli,Piotr Ponikowski,Per Anton Sirnes,Juan Tamargo,Michal Tendera,Adam Torbicki,William Wijns,Stephan Windecker,Marco Valgimigli,Marc J. Claeys,Norbert Donner-Banzhoff,Herbert Frank,Christian Funck-Brentano,Oliver Gaemperli,José Ramón González-Juanatey,Michalis Hamilos,Steen Husted,Stefan James,Kari Kervinen,Steen Dalby Kristensen,Aldo P. Maggioni,Axel R. Pries,Francesco Romeo,Lars Rydén,Maarten L. Simoons,Ph. Gabriel Steg,Adam Timmis,Aylin Yildirir +68 more
TL;DR: The If Inhibitor Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Dysfunction is evaluated as well as patients with Diabetes mellitus for Optimal management of Multivessel disease.
Journal ArticleDOI
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J.V. McMurray,Stamatis Adamopoulos,Stefan D. Anker,Angelo Auricchio,Michael Böhm,Kenneth Dickstein,Volkmar Falk,Gerasimos Filippatos,Cândida Fonseca,Miguel Ángel Gómez-Sánchez,Tiny Jaarsma,Lars Køber,Gregory Y.H. Lip,Aldo P. Maggioni,Alexander Parkhomenko,Burkert Pieske,Bogdan A. Popescu,Per K. Rønnevik,Frans H. Rutten,Juerg Schwitter,Petar M. Seferović,Janina Stępińska,Pedro T. Trindade,Adriaan A. Voors,Faiez Zannad,Andreas M. Zeiher,Jeroen J. Bax,Helmut Baumgartner,Claudio Ceconi,Veronica Dean,Christi Deaton,Robert Fagard,Christian Funck-Brentano,David Hasdai,Arno W. Hoes,Paulus Kirchhof,Juhani Knuuti,Philippe Kolh,Theresa McDonagh,Cyril Moulin,Željko Reiner,Udo Sechtem,Per Anton Sirnes,Michal Tendera,Adam Torbicki,Alec Vahanian,Stephan Windecker,Luis Almenar Bonet,Panayiotis Avraamides,Hisham A. Ben Lamin,Michele Brignole,Antonio Coca,Peter J. Cowburn,Henry J. Dargie,Perry M. Elliott,Frank A. Flachskampf,Guido Francesco Guida,Suzanna M C Hardman,Bernard Iung,Béla Merkely,Christian M. Mueller,John N. Nanas,Olav W. Nielsen,Stein Ørn,John Parissis,Piotr Ponikowski +65 more
TL;DR: Authors/Task Force Members: John J. McMurray (Chairperson) (UK), Stamatis Adamopoulos (Greece), Stefan D. Anker (Germany), Angelo Auricchio (Switzerland), Michael Bohm ( Germany), Kenneth Dickstein (Norway), Volkmar Falk (Sw Switzerland), Gerasimos Filippatos (G Greece), Cândida Fonseca (Portugal), Miguel Angel Gomez-Sanchez (Spain).
Journal ArticleDOI
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
Marc A. Pfeffer,John J.V. McMurray,Eric J. Velazquez,Jean-Lucien Rouleau,Lars Køber,Aldo P. Maggioni,Scott D. Solomon,Karl Swedberg,Frans Van de Werf,Harvey D. White,Jeffrey D. Leimberger,Marc Henis,Susan Edwards,Steven L. Zelenkofske,Mary Ann Sellers,Robert M. Califf +15 more
TL;DR: Valsartan is as effective as captopril in patients who are at high risk for cardiovascular events after myocardial infarction and the combination of the two on mortality in this population of patients.
Journal ArticleDOI
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar,David Preiss,Heather Murray,Paul Welsh,Brendan M. Buckley,Anton J. M. de Craen,Sreenivasa Rao Kondapally Seshasai,John J.V. McMurray,Dilys J. Freeman,J. Wouter Jukema,Peter W. Macfarlane,Chris J. Packard,David J. Stott,Rudi G. J. Westendorp,James Shepherd,Barry R. Davis,Sara L. Pressel,Roberto Marchioli,Rosa Maria Marfisi,Aldo P. Maggioni,Luigi Tavazzi,Gianni Tognoni,John Kjekshus,Terje R. Pedersen,Thomas J. Cook,Antonio M. Gotto,Michael Clearfield,John R. Downs,Haruo Nakamura,Yasuo Ohashi,Kyoichi Mizuno,Kausik K. Ray,Ian Ford +32 more
TL;DR: A meta-analysis of published and unpublished data found that statin therapy is associated with a slightly increased risk of development of diabetes, but the risk is low both in absolute terms and when compared with the reduction in coronary events.